|
1
|
Winton T, Livingston R, Johnson D, Rigas
J, Johnston M, Butts C, et al; National Cancer Institute of Canada
Clinical Trials Group; National Cancer Institute of the United
States Intergroup JBR. 10 Trial Investigators. Vinorelbine plus
cisplatin vs observation in resected non-small-cell lung cancer. N
Engl J Med. 352:2589–2597. 2005.
|
|
2
|
Risch A and Plass C: Lung cancer
epigenetics and genetics. Int J Cancer. 123:1–7. 2008.
|
|
3
|
Stewart DJ: Mechanisms of resistance to
cisplatin and carboplatin. Crit Rev Oncol Hematol. 163:12–31.
2007.
|
|
4
|
Gallwitz B and Bretzel RG: How do we
continue treatment in patients with type 2 diabetes when
therapeutic goals are not reached with oral antidiabetes agents and
lifestyle?. Incretin versus insulin treatment. Diabetes Care.
36:S180–S189. 2013.
|
|
5
|
Evans JM, Donnelly LA, Emslie-Smith AM,
Alessi DR and Morris AD: Metformin and reduced risk of cancer in
diabetic patients. BMJ. 330:1304–1305. 2005.
|
|
6
|
Schneider MB, Matsuzaki H, Haorah J,
Ulrich A, Standop J, Ding XZ, Adrian TE and Pour PM: Prevention of
pancreatic cancer induction in hamsters by metformin.
Gastroenterology. 120:1263–1270. 2001.
|
|
7
|
Anisimov VN, Berstein LM, Egormin PA,
Piskunova TS, Popovich IG, Zabezhinski MA, Kovalenko IG, Poroshina
TE, Semenchenko AV, Provinciali M, Re F and Franceschi C: Effect of
metformin on life span and on the development of spontaneousmammary
tumors in HER-2/neu transgenic mice. Exp Gerontol. 40:685–693.
2005.
|
|
8
|
Bowker SL, Majumdar SR, Veugelers P and
Johnson JA: Increased cancer-related mortality for patients with
type 2 diabetes who use sulfonylureas or insulin. Diabetes Care.
29:254–258. 2006.
|
|
9
|
Buzzai M, Jones RG, Amaravadi RK, Lum JJ,
DeBerardinis RJ, Zhao F, Viollet B and Thompson CB: Systemic
treatment with the antidiabetic drug metformin selectively impairs
p53-deficient tumor cell growth. Cancer Res. 67:6745–6752.
2007.
|
|
10
|
Ben Sahra I, Laurent K, Loubat A,
Giorgetti-Peraldi S, Colosetti P, Auberger P, Tanti JF, Le
Marchand-Brustel Y and Bost F: The antidiabetic drug metformin
exerts an antitumoral effect in vitro and in vivo through a
decrease of cyclin D1 level. Oncogene. 27:3576–3586. 2008.
|
|
11
|
Zhang HT, Wu J, Wen M, Su LJ and Luo H:
Galangin induces apoptosis in hepatocellular carcinoma cells
through the caspase 8/t-Bid mitochondrial pathway. J Asian Nat Prod
Res. 14:626–633. 2012.
|
|
12
|
Wu J, Hu CP, Gu QH, Li YP and Song M:
Trichostatin A sensitizes cisplatin-resistant A549 cells to
apoptosis by up-regulating death-associated protein kinase. Acta
Pharmacol Sin. 31:93–101. 2010.
|
|
13
|
Jemal A, Murray T, Ward E, Samuels A,
Tiwari RC, Ghafoor A, Feuer EJ and Thun MJ: Cancer statistics,
2005. CA Cancer J Clin. 55:10–30. 2005.
|
|
14
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007.
|
|
15
|
Florea AM and Büsselberg D: Cisplatin as
an anti-tumor drug: cellular mechanisms of activity, drug
resistance and induced side effects. Cancers (Basel). 15:1351–1371.
2011.
|
|
16
|
Jiang Q, Li F, Shi K, Wu P, An J, Yang Y
and Xu C: ATF4 activation by the p38MAPK-eIF4E axis mediates
apoptosis and autophagy induced by selenite in Jurkat cells. FEBS
Lett. 587:2420–2429. 2013.
|
|
17
|
Neoh CA, Wang RY, Din ZH, Su JH, Chen YK,
Tsai FJ, Weng SH and Wu YJ: Induction of apoptosis by sinulariolide
from soft coral through mitochondrial-related and p38 MAPK pathways
on human bladder carcinoma cells. Mar Drugs. 10:2893–2911.
2012.
|
|
18
|
Mandal C, Dutta A, Mallick A, Chandra S,
Misra L, Sangwan RS and Mandal C: Withaferin A induces apoptosis by
activating p38 mitogen-activated protein kinase signaling cascade
in leukemic cells of lymphoid and myeloid origin through
mitochondrial death cascade. Apoptosis. 13:1450–1464. 2008.
|
|
19
|
Chang HL, Chen CY, Hsu YF, Kuo WS, Ou G,
Chiu PT, Huang YH and Hsu MJ: Simvastatin induced HCT116 colorectal
cancer cell apoptosis through p38MAPK-p53-survivin signaling
cascade. Biochim Biophys Acta. 1830:4053–4064. 2013.
|
|
20
|
Yang X, Yao J, Luo Y, Han Y, Wang Z and Du
L: P38 MAP kinase mediates apoptosis after genipin treatment in
non-small-cell lung cancer H1299 cells via a mitochondrial
apoptotic cascade. J Pharmacol Sci. 121:272–281. 2013.
|
|
21
|
Khan R, Khan AQ, Qamar W, Lateef A, Tahir
M, Rehman MU, Ali F and Sultana S: Chrysin protects against
cisplatin-induced colon toxicity via amelioration of oxidative
stress and apoptosis: probable role of p38MAPK and p53. Toxicol
Appl Pharmacol. 258:315–329. 2012.
|
